Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | plexin a4 | 0.0596 | 0.4573 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0215 | 0.1103 | 0.2412 |
Schistosoma mansoni | plexin | 0.0502 | 0.3713 | 1 |
Echinococcus granulosus | semaphorin 1A | 0.0215 | 0.1103 | 0.1103 |
Loa Loa (eye worm) | sema domain-containing protein | 0.0215 | 0.1103 | 0.2412 |
Echinococcus granulosus | plexin a4 | 0.0596 | 0.4573 | 0.4573 |
Trichomonas vaginalis | Clan MA, family M8, leishmanolysin-like metallopeptidase | 0.0094 | 0 | 0.5 |
Schistosoma mansoni | plexin | 0.0286 | 0.175 | 0.4713 |
Brugia malayi | hypothetical protein | 0.0215 | 0.1103 | 0.2412 |
Loa Loa (eye worm) | hypothetical protein | 0.0215 | 0.1103 | 0.2412 |
Trichomonas vaginalis | Clan MA, family M8, leishmanolysin-like metallopeptidase | 0.0094 | 0 | 0.5 |
Schistosoma mansoni | semaphorin 5-related | 0.0215 | 0.1103 | 0.297 |
Loa Loa (eye worm) | hypothetical protein | 0.0215 | 0.1103 | 0.2412 |
Brugia malayi | Sema domain containing protein | 0.0215 | 0.1103 | 0.2412 |
Schistosoma mansoni | hypothetical protein | 0.0286 | 0.175 | 0.4713 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0094 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0094 | 0 | 0.5 |
Brugia malayi | plexin A | 0.0596 | 0.4573 | 1 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0247 | 0.139 | 0.304 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.0247 | 0.139 | 0.304 |
Schistosoma mansoni | hypothetical protein | 0.0215 | 0.1103 | 0.297 |
Onchocerca volvulus | 0.0215 | 0.1103 | 0.1849 | |
Echinococcus multilocularis | semaphorin 5B | 0.0215 | 0.1103 | 0.2412 |
Loa Loa (eye worm) | hypothetical protein | 0.0286 | 0.175 | 0.3827 |
Brugia malayi | hypothetical protein | 0.0215 | 0.1103 | 0.2412 |
Brugia malayi | Sema domain containing protein | 0.0215 | 0.1103 | 0.2412 |
Loa Loa (eye worm) | hypothetical protein | 0.0215 | 0.1103 | 0.2412 |
Brugia malayi | Plexin repeat family protein | 0.0502 | 0.3713 | 0.8119 |
Loa Loa (eye worm) | hypothetical protein | 0.0215 | 0.1103 | 0.2412 |
Schistosoma mansoni | hypothetical protein | 0.0215 | 0.1103 | 0.297 |
Loa Loa (eye worm) | hypothetical protein | 0.0502 | 0.3713 | 0.8119 |
Echinococcus granulosus | semaphorin 5B | 0.0215 | 0.1103 | 0.1103 |
Trichomonas vaginalis | Clan MA, family M8, leishmanolysin-like metallopeptidase | 0.0094 | 0 | 0.5 |
Loa Loa (eye worm) | sema domain-containing protein | 0.0215 | 0.1103 | 0.2412 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0094 | 0 | 0.5 |
Onchocerca volvulus | Tyrosine kinase homolog | 0.0195 | 0.0916 | 0.1266 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0128 | 0.0306 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0094 | 0 | 0.5 |
Trichomonas vaginalis | Clan MA, family M8, leishmanolysin-like metallopeptidase | 0.0094 | 0 | 0.5 |
Onchocerca volvulus | 0.0502 | 0.3713 | 1 | |
Trichomonas vaginalis | conserved hypothetical protein | 0.0094 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0215 | 0.1103 | 0.2412 |
Entamoeba histolytica | tyrosin kinase, putative | 0.0128 | 0.0306 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0094 | 0 | 0.5 |
Trichomonas vaginalis | Clan MA, family M8, leishmanolysin-like metallopeptidase | 0.0094 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0094 | 0 | 0.5 |
Loa Loa (eye worm) | plexin A | 0.0596 | 0.4573 | 1 |
Echinococcus multilocularis | hypothetical protein | 0.0215 | 0.1103 | 0.2412 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 0.1 uM | Cytotoxicity against human non-small-cell lung carcinoma cell line H460 (NSCLC-H460) | ChEMBL. | 11563925 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.